Abstract:Abstract Background Hepatic inflammation is the major risk factor of hepatocellular carcinoma (HCC). However, the underlying mechanism by which hepatic inflammation progresses to HCC is poorly understood. This study was designed to investigate the role of ETS translocation variant 4 (ETV4) in linking hepatic inflammation to HCC. Methods Quantitative real‐time PCR and immunoblotting were used to detect the expression of ETV4 in HCC tissues and cell lines. RNA sequencing and luciferase reporter assays were performed to identify the target genes of ETV4. Hepatocyte‐specific ETV4 ‐knockout ( ETV4 fl/fl, alb‐cre ) and transgenic ( ETV4 Hep‐TG ) mice and diethylnitrosamine‐carbon tetrachloride (DEN‐CCL 4 ) treatment experiments were applied to investigate the function of ETV4 in vivo . The Cancer Genome Atlas (TCGA) database mining and pathological analysis were carried out to determine the correlation of ETV4 with tumor necrosis factor‐alpha (TNF‐α) and mitogen‐activated protein kinase 11 (MAPK11). Results We revealed that ETV4 was highly expressed in HCC. High levels of ETV4 predicted a poor survival rate of HCC patients. Then we identified ETV4 as a transcription activator of TNF‐α and MAPK11. ETV4 was positively correlated with TNF‐α and MAPK11 in HCC patients. As expected, an increase in hepatic TNF‐α secretion and macrophage accumulation were observed in the livers of ETV4 Hep‐TG mice. The protein levels of TNF‐α, MAPK11, and CD68 were significantly higher in the livers of ETV4 Hep‐TG mice compared with wild type mice but lower in ETV4 fl/fl, alb‐cre mice compared with ETV4 fl/fl mice as treated with DEN‐CCL 4 , indicating that ETV4 functioned as a driver of TNF‐α/MAPK11 expression and macrophage accumulation during hepatic inflammation. Hepatocyte‐specific knockout of ETV4 significantly prevented development of DEN‐CCL 4 ‐induced HCC, while transgenic expression of ETV4 promoted growth of HCC. Conclusions ETV4 promoted hepatic inflammation and HCC by activating transcription of TNF‐α and MAPK11. Both the ETV4/TNF‐α and ETV4/MAPK11 axes represented two potential therapeutic targets for highly associated hepatic inflammation and HCC. ETV4+TNF‐α were potential prognostic markers for HCC patients.

ETV4 promotes the progression of cholangiocarcinoma by regulating glycolysis via the TGF-β signaling

ETV4 is a Theranostic Target in Clear Cell Renal Cell Carcinoma That Promotes Metastasis by Activating the Pro-Metastatic Gene FOSL1 in a PI3K-AKT Dependent Manner.

Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells

Elevated ETV4 expression in cholangiocarcinoma is linked to poor prognosis and may guide targeted therapies

Biological effect of ETV4 and the underlying mechanism of its regulatory effect on epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma cells

ETV4 promotes breast cancer cell stemness by activating glycolysis and CXCR4-mediated sonic Hedgehog signaling

ETV4 Facilitates Angiogenesis in Hepatocellular Carcinoma by Upregulating MMP14 Expression

FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition

ETV4 Promotes Pancreatic Ductal Adenocarcinoma Metastasis Through Activation of the CXCL13/CXCR5 Signaling Axis.

Altered Expression of ETV1 and Its Contribution to Tumorigenic Phenotypes in Gastrointestinal Stromal Tumors.

Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF‐α signaling

ETV4 transcriptionally activates HES1 and promotes Stat3 phosphorylation to promote malignant behaviors of colon adenocarcinoma

FGF19/FGFR4-mediated Elevation of ETV4 Facilitates Hepatocellular Carcinoma Metastasis by Upregulating PD-L1 and CCL2

ETV4 Potentiates Nuclear YAP Retention and Activities to Enhance the Progression of Hepatocellular Carcinoma.

Study on the Mechanism of FOXA2 Activation on Glutathione Metabolic Reprogramming Mediated by ETV4 Transcription to Facilitate Colorectal Cancer Malignant Progression

Guanine nucleotide exchange factor T exerts the cancer-promoting function in cholangiocarcinoma by enhancing the Wnt-GSK-3β-β-catenin cascade via regulation of Rac1/Cdc42

ETV4/NSUN2 Axis modulates aerobic glycolysis and malignancy in HSCC

HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET

ETV5 Overexpression Promotes Progression of Esophageal Squamous Cell Carcinoma by Upregulating SKA1 and TRPV2

Oncogenic role and drug sensitivity of ETV4 in human tumors: a pan-cancer analysis

ETV7 promotes colorectal cancer progression through upregulation of IFIT3